Results for tag: "Onzetra"

Onzetra is a market within the context of Central Nervous System (CNS) Drugs. CNS drugs are used to treat a variety of neurological conditions, including depression, anxiety, and schizophrenia. Onzetra is a sub-market of CNS drugs that focuses on treatments for migraine headaches. Onzetra drugs are designed to reduce the frequency and severity of migraine headaches, as well as reduce the associated symptoms. Onzetra drugs are typically administered as an injection, and are often used in combination with other medications. Some companies in the Onzetra market include Allergan, Amgen, Eli Lilly, and Teva Pharmaceuticals. Allergan produces a drug called Aimovig, which is a monoclonal antibody designed to reduce the frequency of migraine headaches. Amgen produces a drug called Aimovig, which is a monoclonal antibody designed to reduce the frequency of migraine headaches. Eli Lilly produces a drug called Emgality, which is a monoclonal antibody designed to reduce the frequency of migraine headaches. Teva Pharmaceuticals produces a drug called Ajovy, which is a monoclonal antibody designed to reduce the frequency of migraine headaches. Show Less Read more